Hypoxia-preconditioned adipose tissue-derived mesenchymal stem cell increase the survival and gene expression of engineered neural stem cells in a spinal cord injury model

Neuroscience Letters

Volumn 472, Issue 3, 2010, Pages 215-219

  Oh, Jin Soo ^a,b   Ha, Yoon ^a   An, Sung Su ^a,b   Khan, Momin ^a,b   Pennant, William A ^a   Kim, Hyo Jin ^a,b   Yoon, Do Heum ^a,b   Lee, Minhyung ^c   Kim, Keung Nyun ^a  

^a Dongguk University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Co transplantation; Gene therapy; Hypoxia preconditioning; Spinal cord injury; Stem cell therapy

Indexed keywords

BETA1 INTEGRIN; CD31 ANTIGEN; ENDOGLIN; PROTEIN BAX; THY 1 ANTIGEN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; GENE EXPRESSION; HYPOXIA; IN VITRO STUDY; ISCHEMIC PRECONDITIONING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; SPINAL CORD INJURY; STEM CELL GENE THERAPY;

ADIPOSE TISSUE; ANIMALS; CELL HYPOXIA; CELL SURVIVAL; GENE EXPRESSION; GENETIC ENGINEERING; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE TISSUE; RATS; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION;

EID: 77649273521     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.02.008     Document Type: Article

References (18)

1. Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., Osaki M., Kawamata M., Kato T., Okochi H., and Ochiya T. IFATS series: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells (AT-MSCs) after transplantation into mice with liver injury. Stem Cells 26 10 (2008) 2705-2712
2. Birbes H., Luberto C., Yi-Te Hsu S., Hannun Y., and Obeid L. A mitochondrial pool of sphingomyelin is involved in TNFα-induced Bax translocation to mitochondria. Biochemical Journal 386 (2005) 445
3. Chang S., Chuang H., Chen Y., Chen J., Chung H., Lu Y., Lin H., Tai C., and Lou J. Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regeneration. Gene Therapy 10 (2003) 2013-2019
4. Hofstetter C., Schwarz E., Hess D., Widenfalk J., El Manira A., Prockop D., and Olson L. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proceedings of the National Academy of Sciences 99 (2002) 2199
5. Hu X., Yu S., Fraser J., Lu Z., Ogle M., Wang J., and Wei L. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. The Journal of Thoracic and Cardiovascular Surgery 135 (2008) 799
6. Kang S., Shin M., Jung J., Kim Y., and Kim C. Autologous adipose tissue-derived stromal cells for treatment of spinal cord injury. Stem Cells and Development 15 (2006) 583-594
7. Kim S. Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 24 (2004) 159-171
8. Li Y., Chen J., Chen X., Wang L., Gautam S., Xu Y., Katakowski M., Zhang L., Lu M., and Janakiraman N. Human marrow stromal cell therapy for stroke in rat neurotrophins and functional recovery. Neurology 59 (2002) 514-523
9. Li W., Ma N., Ong L., Nesselmann C., Klopsch C., Ladilov Y., Furlani D., Piechaczek C., Moebius J., and Lutzow K. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25 (2007) 2118
10. Liu M., Liu M., Shen Y., Ryu H., Kim H., Klupsch K., Downward J., and Hong S. Omi is a mammalian heat-shock protein that selectively binds and detoxifies oligomeric amyloid-β. Journal of Cell Science 122 (2009) 1917
11. Lu P., Jones L., Snyder E., and Tuszynski M. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Experimental Neurology 181 (2003) 115-129
12. Mangi A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J., and Dzau V. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nature Medicine 9 (2003) 1195-1201
13. Ohnishi S., Yasuda T., Kitamura S., and Nagaya N. Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells. Stem Cells 25 (2007) 1166
14. Peng L., Jia Z., Yin X., Zhang X., Liu Y., Chen P., Ma K., and Zhou C. Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cells and Development 17 (2008) 761-774
15. Theus M., Wei L., Cui L., Francis K., Hu X., Keogh C., and Yu S. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Experimental Neurology 210 (2008) 656-670
16. Uemura R., Xu M., Ahmad N., and Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circulation Research 98 (2006) 1414
17. Wei L., Cui L., Snider B., Rivkin M., Yu S., Lee C., Adams L., Gottlieb D., Johnson E., and Yu S. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiology of Disease 19 (2005) 183-193
18. Zwezdaryk K., Coffelt S., Figueroa Y., Liu J., Phinney D., LaMarca H., Florez L., Morris C., Hoyle G., and Scandurro A. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells. Experimental Hematology 35 (2007) 640-652